Inj methotrexate sodium 50mg
Products billed under this code include Methotrexate Sodium.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Methotrexate Sodium.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Methotrexate Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9367-01 | 20 | $58.18 |
| Methotrexate Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9519-10 | 10 | $29.09 |
| Methotrexate Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9830-01 | 20 | $58.18 |
| Methotrexate Sodium | Teva Parenteral Medicines, Inc. | 00703-3671-01 | 1 | $2.909 |
| Methotrexate Sodium | Teva Parenteral Medicines, Inc. | 00703-3675-01 | 5 | $14.545 |
| Methotrexate Sodium | Teva Parenteral Medicines, Inc. | 00703-3678-01 | 20 | $58.18 |
| Methotrexate Sodium | Teva Parenteral Medicines, Inc. | 00703-3678-81 | 20 | $58.18 |
| Methotrexate Sodium | ACCORD HEALTHCARE INC | 16729-0277-03 | 5 | $14.545 |
| Methotrexate Sodium | Accord Healthcare Inc | 16729-0277-30 | 1 | $2.909 |
| Methotrexate Sodium | Accord Healthcare Inc | 16729-0277-35 | 20 | $58.18 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Methotrexate Sodium | Pfizer Inc | 61703-0124-40 | 20 | $58.18 |
| Methotrexate Sodium | Pfizer Inc | 61703-0161-05 | 5 | $14.545 |
| Methotrexate Sodium | Pfizer Inc | 61703-0350-10 | 5 | $14.545 |
| Methotrexate Sodium | Pfizer Inc | 61703-0350-38 | 5 | $14.545 |
| Methotrexate Sodium | Pfizer Inc | 61703-0408-25 | 20 | $58.18 |
| Methotrexate Sodium | Pfizer Inc | 61703-0408-41 | 20 | $58.18 |
| Methotrexate Sodium | FreseniUS Kabi USA, LLC | 63323-0122-50 | 20 | $58.18 |
| Methotrexate Sodium | FreseniUS Kabi USA, LLC | 63323-0123-10 | 5 | $14.545 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.909 | −$0.032 | 50 MG | Inj methotrexate sodium 50mg | v1, posted September 17, 2026 |
| 3Q26 | $2.941 | +$0.264 | 50 MG | Inj methotrexate sodium 50mg | v1, posted September 15, 2026 |
| 2Q26 | $2.677 | +$0.098 | 50 MG | Inj methotrexate sodium 50mg | v1, posted September 15, 2026 |
| 1Q26 | $2.579 | −$0.237 | 50 MG | Inj methotrexate sodium 50mg | v1, posted September 15, 2026 |
| 4Q25 | $2.816 | +$0.553 | 50 MG | Inj methotrexate sodium 50mg | v1, posted September 8, 2026 |
| 3Q25 | $2.263 | −$0.321 | 50 MG | Inj methotrexate sodium 50mg | v1, posted March 10, 2026 |
| 2Q25 | $2.584 | −$0.789 | 50 MG | Inj methotrexate sodium 50mg | v1, posted March 10, 2026 |
| 1Q25 | $3.373 | +$0.65 | 50 MG | Inj methotrexate sodium 50mg | v1, posted December 19, 2025 |
| 4Q24 | $2.723 | +$0.142 | 50 MG | Inj methotrexate sodium 50mg | v1, posted June 11, 2025 |
| 3Q24 | $2.581 | +$0.009 | 50 MG | Methotrexate sodium inj | v1, posted June 11, 2025 |
| 2Q24 | $2.572 | −$0.461 | 50 MG | Methotrexate sodium inj | v1, posted March 11, 2025 |
| 1Q24 | $3.033 | +$0.708 | 50 MG | Methotrexate sodium inj | v1, posted December 19, 2024 |
| 4Q23 | $2.325 | −$0.385 | 50 MG | Methotrexate sodium inj | v1, posted October 10, 2024 |
| 3Q23 | $2.71 | +$0.263 | 50 MG | Methotrexate sodium inj | v1, posted June 5, 2024 |
| 2Q23 | $2.447 | +$0.256 | 50 MG | Methotrexate sodium inj | v1, posted February 23, 2024 |
| 1Q23 | $2.191 | −$0.43 | 50 MG | Methotrexate sodium inj | v1, posted December 6, 2023 |
| 4Q22 | $2.621 | +$0.647 | 50 MG | Methotrexate sodium inj | v1, posted June 22, 2023 |
| 3Q22 | $1.974 | −$0.386 | 50 MG | Methotrexate sodium inj | v1, posted June 9, 2023 |
| 2Q22 | $2.36 | +$0.289 | 50 MG | Methotrexate sodium inj | v1, posted December 14, 2022 |
| 1Q22 | $2.071 | −$0.086 | 50 MG | Methotrexate sodium inj | v1, posted June 8, 2022 |
| 4Q21 | $2.157 | −$0.076 | 50 MG | Methotrexate sodium inj | v1, posted June 2, 2022 |
| 3Q21 | $2.233 | +$0.118 | 50 MG | Methotrexate sodium inj | v1, posted June 2, 2022 |
| 2Q21 | $2.115 | +$0.012 | 50 MG | Methotrexate sodium inj | v1, posted March 1, 2022 |
| 1Q21 | $2.103 | – | 50 MG | Methotrexate sodium inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.